November, 2023
November 2023
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Volastra Therapeutics dosed the first patient in their Phase I/II clinical trial of VLS-1488
03/11/2023 12:06

Volastra Therapeutics dosed the first patient in their Phase I/II clinical trial of VLS-1488

Volastra Therapeutics shared on their LinkedIn page:

”We’ve dosed the first patient in our Phase I/II clinical trial of VLS-1488, our internally discovered KIF18A inhibiting drug designed to treat patients with advanced cancers characterized by high levels of chromosomal instability.”

For more information click here.
Source: Volastra Therapeutics/LinkedIn